Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Alzheimer's Disease

  Free Subscription


Articles published in Brain

Retrieve available abstracts of 213 articles:
HTML format



Single Articles


    February 2024
  1. YANG HS, Yau WW, Carlyle BC, Trombetta BA, et al
    Plasma VEGFA and PGF impact longitudinal tau and cognition in preclinical Alzheimer's disease.
    Brain. 2024 Feb 5:awae034. doi: 10.1093.
    PubMed     Abstract available


  2. AHMED H, Wang Y, Griffiths WJ, Levey AI, et al
    Brain cholesterol and Alzheimer's disease: challenges and opportunities in probe and drug development.
    Brain. 2024 Feb 1:awae028. doi: 10.1093.
    PubMed     Abstract available


  3. ALBERT-GASCO H, Smith HL, Alvarez-Castelao B, Swinden D, et al
    Trazodone rescues dysregulated synaptic and mitochondrial nascent proteomes in prion neurodegeneration.
    Brain. 2024;147:649-664.
    PubMed     Abstract available


    January 2024
  4. KUMAR M, Quittot N, Dujardin S, Schlaffner CN, et al
    Alzheimer proteopathic tau seeds are biochemically a forme fruste of mature paired helical filaments.
    Brain. 2024 Jan 18:awad378. doi: 10.1093.
    PubMed     Abstract available


  5. KIIANITSA K, Lukes ME, Hayes BJ, Brutman J, et al
    TREM2 variants that cause early dementia and increase Alzheimer's disease risk affect gene splicing.
    Brain. 2024 Jan 16:awae014. doi: 10.1093.
    PubMed     Abstract available


  6. HAN Y, Chen K, Zhang B, Yu H, et al
    Maf1 loss regulates spinogenesis and attenuates cognitive impairment in Alzheimer's disease.
    Brain. 2024 Jan 16:awae015. doi: 10.1093.
    PubMed     Abstract available


  7. QIN C, Chen M, Dong MH, Yang S, et al
    Soluble TREM2 triggers microglial dysfunction in neuromyelitis optica spectrum disorders.
    Brain. 2024;147:163-176.
    PubMed     Abstract available


    December 2023
  8. SAMANTA S, Akhter F, Roy A, Chen D, et al
    New cyclophilin D inhibitor rescues mitochondrial and cognitive function in Alzheimer's disease.
    Brain. 2023 Dec 26:awad432. doi: 10.1093.
    PubMed     Abstract available


  9. SPOTORNO N, Strandberg O, Stomrud E, Janelidze S, et al
    Diffusion MRI tracks cortical microstructural changes during the early stages of Alzheimer's disease.
    Brain. 2023 Dec 21:awad428. doi: 10.1093.
    PubMed     Abstract available


  10. STOUFFER KM, Grande X, Duezel E, Johansson M, et al
    Amidst an amygdala renaissance in Alzheimer's disease.
    Brain. 2023 Dec 18:awad411. doi: 10.1093.
    PubMed     Abstract available


  11. YUYAMA K, Sun H, Fujii R, Hemmi I, et al
    Extracellular vesicle proteome unveils cathepsin B connection to Alzheimer's disease pathogenesis.
    Brain. 2023 Dec 10:awad361. doi: 10.1093.
    PubMed     Abstract available


  12. TARUTANI A, Kametani F, Tahira M, Saito Y, et al
    Distinct tau folds initiate templated seeding and alter the post-translational modification profile.
    Brain. 2023;146:4988-4999.
    PubMed     Abstract available


  13. GUBERT C, Hannan AJ
    Microbial manipulation of memories and minds.
    Brain. 2023;146:4791-4793.
    PubMed    


    November 2023
  14. QUESNEL MJ, Labonte A, Picard C, Zetterberg H, et al
    Insulin-like growth factor binding protein-2 in at-risk adults and autopsy-confirmed Alzheimer brains.
    Brain. 2023 Nov 22:awad398. doi: 10.1093.
    PubMed     Abstract available


  15. SILVA-RODRIGUEZ J, Labrador-Espinosa MA, Moscoso A, Scholl M, et al
    Characteristics of amnestic patients with hypometabolism patterns suggestive of Lewy body pathology.
    Brain. 2023;146:4520-4531.
    PubMed     Abstract available


  16. HAMPEL H, Elhage A, Cho M, Apostolova LG, et al
    Amyloid-related imaging abnormalities (ARIA): radiological, biological and clinical characteristics.
    Brain. 2023;146:4414-4424.
    PubMed     Abstract available


  17. RAMANAN VK, Gebre RK, Graff-Radford J, Hofrenning E, et al
    Genetic risk scores enhance the diagnostic value of plasma biomarkers of brain amyloidosis.
    Brain. 2023;146:4508-4519.
    PubMed     Abstract available


    October 2023
  18. GRABRUCKER S, Marizzoni M, Silajdzic E, Lopizzo N, et al
    Microbiota from Alzheimer's patients induce deficits in cognition and hippocampal neurogenesis.
    Brain. 2023 Oct 18:awad303. doi: 10.1093.
    PubMed     Abstract available


  19. TUNOLD JA, Tan MMX, Koga S, Geut H, et al
    Lysosomal polygenic risk is associated with the severity of neuropathology in Lewy body disease.
    Brain. 2023;146:4077-4087.
    PubMed     Abstract available


  20. KEPP KP, Robakis NK, Hoilund-Carlsen PF, Sensi SL, et al
    The amyloid cascade hypothesis: an updated critical review.
    Brain. 2023;146:3969-3990.
    PubMed     Abstract available


  21. DU F, Yu Q, Swerdlow RH, Waites CL, et al
    Glucocorticoid-driven mitochondrial damage stimulates Tau pathology.
    Brain. 2023;146:4378-4394.
    PubMed     Abstract available


    September 2023
  22. HARDY J, Mummery C
    Reply: Lecanemab: turning point, or status quo? An ethics perspective.
    Brain. 2023;146:e73.
    PubMed    


  23. BOCANCEA DI, Svenningsson AL, van Loenhoud AC, Groot C, et al
    Determinants of cognitive and brain resilience to tau pathology: a longitudinal analysis.
    Brain. 2023;146:3719-3734.
    PubMed     Abstract available


  24. DALY T
    Lecanemab: turning point, or status quo? An ethics perspective.
    Brain. 2023;146:e71-e72.
    PubMed    


  25. COOMANS EM, Tomassen J, Ossenkoppele R, Tijms BM, et al
    Genetically identical twin-pair difference models support the amyloid cascade hypothesis.
    Brain. 2023;146:3735-3746.
    PubMed     Abstract available


    August 2023
  26. KERAMIDIS I, McAllister BB, Bourbonnais J, Wang F, et al
    Restoring neuronal chloride extrusion reverses cognitive decline linked to Alzheimer's disease mutations.
    Brain. 2023 Aug 8:awad250. doi: 10.1093.
    PubMed     Abstract available


  27. JUNG Y, Damoiseaux JS
    The potential of blood neurofilament light as a marker of neurodegeneration for Alzheimer's disease.
    Brain. 2023 Aug 4:awad267. doi: 10.1093.
    PubMed     Abstract available


  28. WUESTEFELD A, Pichet Binette A, Berron D, Spotorno N, et al
    Age-related and amyloid-beta-independent tau deposition and its downstream effects.
    Brain. 2023;146:3192-3205.
    PubMed     Abstract available


  29. RAHAYEL S, Tremblay C, Vo A, Misic B, et al
    Mitochondrial function-associated genes underlie cortical atrophy in prodromal synucleinopathies.
    Brain. 2023;146:3301-3318.
    PubMed     Abstract available


  30. MCMILLAN PJ, Benbow SJ, Uhrich R, Saxton A, et al
    Tau-RNA complexes inhibit microtubule polymerization and drive disease-relevant conformation change.
    Brain. 2023;146:3206-3220.
    PubMed     Abstract available


    July 2023
  31. GARCIA AM, de Leon J, Tee BL, Blasi DE, et al
    Speech and language markers of neurodegeneration: a call for global equity.
    Brain. 2023 Jul 27:awad253. doi: 10.1093.
    PubMed     Abstract available


  32. AKSMAN LM, Oxtoby NP, Scelsi MA, Wijeratne PA, et al
    A data-driven study of Alzheimer's disease related amyloid and tau pathology progression.
    Brain. 2023 Jul 11:awad232. doi: 10.1093.
    PubMed     Abstract available


  33. YOUNG AL, Vogel JW, Robinson JL, McMillan CT, et al
    Data-driven neuropathological staging and subtyping of TDP-43 proteinopathies.
    Brain. 2023;146:2975-2988.
    PubMed     Abstract available


    June 2023

  34. Correction to: Brain-derived tau: a novel blood-based biomarker for Alzheimer's disease-type neurodegeneration.
    Brain. 2023 Jun 27:awad208. doi: 10.1093.
    PubMed    


  35. VAN DER ENDE EL, In 't Veld SGJG, Hanskamp I, van der Lee S, et al
    CSF proteomics in autosomal dominant Alzheimer's disease highlights parallels with sporadic disease.
    Brain. 2023 Jun 22:awad213. doi: 10.1093.
    PubMed     Abstract available


  36. BANERJEE G, Collinge J, Fox NC, Lashley T, et al
    Clinical considerations in early-onset cerebral amyloid angiopathy.
    Brain. 2023 Jun 6:awad193. doi: 10.1093.
    PubMed     Abstract available


  37. SCHOONHOVEN DN, Coomans EM, Millan AP, van Nifterick AM, et al
    Tau protein spreads through functionally connected neurons in Alzheimer's disease: a combined MEG/PET study.
    Brain. 2023 Jun 5:awad189. doi: 10.1093.
    PubMed     Abstract available



  38. Correction: The most valuable player or the tombstone: is tau the correct target to treat Alzheimer's disease?
    Brain. 2023 Jun 1:awad176. doi: 10.1093.
    PubMed    


  39. EDWARDS HM, Wallace CE, Gardiner WD, Doherty BM, et al
    Sex-dependent effects of acute stress on amyloid-beta in male and female mice.
    Brain. 2023;146:2268-2274.
    PubMed     Abstract available


  40. ROBINSON JL, Xie SX, Baer DR, Suh E, et al
    Pathological combinations in neurodegenerative disease are heterogeneous and disease-associated.
    Brain. 2023;146:2557-2569.
    PubMed     Abstract available


    May 2023
  41. ZHU M, Xiao B, Xue T, Qin S, et al
    Cdc42GAP deficiency contributes to the Alzheimer's disease phenotype.
    Brain. 2023 May 31:awad184. doi: 10.1093.
    PubMed     Abstract available


  42. DAS V, Hajduch M
    Randomizing for Alzheimer's disease drug trials should consider the cancer history of participants.
    Brain. 2023 May 27:awad177. doi: 10.1093.
    PubMed    


  43. HARDY J, Mummery C
    Reply: Unblinding in the lecanemab trial in Alzheimer's disease.
    Brain. 2023 May 23:awad201. doi: 10.1093.
    PubMed    


  44. VAN GOOL WA
    Unblinding in the lecanemab trial in Alzheimer's disease.
    Brain. 2023 May 18:awad171. doi: 10.1093.
    PubMed    


  45. KORETSKY MJ, Alvarado C, Makarious MB, Vitale D, et al
    Genetic risk factor clustering within and across neurodegenerative diseases.
    Brain. 2023 May 16:awad161. doi: 10.1093.
    PubMed     Abstract available


  46. JIANG J, Johnson JCS, Requena-Komuro MC, Benhamou E, et al
    Comprehension of acoustically degraded speech in Alzheimer's disease and primary progressive aphasia.
    Brain. 2023 May 15:awad163. doi: 10.1093.
    PubMed     Abstract available


  47. YOUNES K, Sha SJ
    The MVP or the tombstone: is tau the correct target to treat Alzheimer's disease?
    Brain. 2023 May 8:awad151. doi: 10.1093.
    PubMed    


    April 2023
  48. GOSSYE H, Van Mossevelde S, Sieben A, Bjerke M, et al
    Patients carrying the mutation p.R406W in MAPT present with non-conforming phenotypic spectrum.
    Brain. 2023;146:1624-1636.
    PubMed     Abstract available


  49. PONNUSAMY M, Wang S, Yuksel M, Hansen MT, et al
    Loss of forebrain BIN1 attenuates hippocampal pathology and neuroinflammation in a tauopathy model.
    Brain. 2023;146:1561-1579.
    PubMed     Abstract available


  50. NAM MH, Ko HY, Kim D, Lee S, et al
    Visualizing reactive astrocyte-neuron interaction in Alzheimer's disease using 11C-acetate and 18F-FDG.
    Brain. 2023 Apr 17:awad037. doi: 10.1093.
    PubMed     Abstract available


  51. MATTSSON-CARLGREN N, Palmqvist S
    The emerging era of staging Alzheimer's disease pathology using plasma biomarkers.
    Brain. 2023 Apr 6:awad112. doi: 10.1093.
    PubMed    


    March 2023

  52. Correction to: Blood-brain barrier opening of the default mode network in Alzheimer's disease with magnetic resonance-guided focused ultrasound.
    Brain. 2023 Mar 22:awad082. doi: 10.1093.
    PubMed    


  53. DONADIO V, Incensi A, Rizzo G, Westermark GT, et al
    Phosphorylated alpha-synuclein in skin Schwann cells: a new biomarker for multiple system atrophy.
    Brain. 2023;146:1065-1074.
    PubMed     Abstract available


  54. GREVE HJ, Dunbar AL, Lombo CG, Ahmed C, et al
    The bidirectional lung brain-axis of amyloid-beta pathology: ozone dysregulates the peri-plaque microenvironment.
    Brain. 2023;146:991-1005.
    PubMed     Abstract available


    February 2023
  55. HARDY J, Mummery C
    An anti-amyloid therapy works for Alzheimer's disease: why has it taken so long and what is next?
    Brain. 2023 Feb 17:awad049. doi: 10.1093.
    PubMed    


  56. JACK CR, Wiste HJ, Algeciras-Schimnich A, Figdore DJ, et al
    Predicting amyloid PET and tau PET stages with plasma biomarkers.
    Brain. 2023 Feb 15:awad042. doi: 10.1093.
    PubMed     Abstract available


  57. HUSAIN M
    Screening for Alzheimer's disease: plasma biomarkers and what else?
    Brain. 2023;146:407-408.
    PubMed    


  58. FLORIAN H, Wang D, Arnold SE, Boada M, et al
    Tilavonemab in early Alzheimer's disease: results from a phase 2, randomized, double-blind study.
    Brain. 2023 Feb 2:awad024. doi: 10.1093.
    PubMed     Abstract available


  59. KOCH G, Martorana A
    Reply: Can transcranial magnetic stimulation rescue dopaminergic signalling in Alzheimer disease?
    Brain. 2023 Feb 2:awad020. doi: 10.1093.
    PubMed    


  60. D'AMELIO M, Di Lazzaro V
    Can transcranial magnetic stimulation rescue dopaminergic signalling in Alzheimer disease?
    Brain. 2023 Feb 2:awad019. doi: 10.1093.
    PubMed    


    January 2023
  61. MARUSZAK A, Silajdzic E, Lee H, Murphy T, et al
    Predicting progression to Alzheimer's disease with human hippocampal progenitors exposed to serum.
    Brain. 2023 Jan 27:awac472. doi: 10.1093.
    PubMed     Abstract available


  62. MENG Y, Goubran M, Rabin JS, McSweeney M, et al
    Blood-brain barrier opening of the default mode network in Alzheimer's disease with magnetic resonance-guided focused ultrasound.
    Brain. 2023 Jan 25:awac459. doi: 10.1093.
    PubMed     Abstract available


  63. PERNECZKY R, Jessen F, Grimmer T, Levin J, et al
    Anti-amyloid antibody therapies in Alzheimer's disease.
    Brain. 2023 Jan 19:awad005. doi: 10.1093.
    PubMed     Abstract available


  64. JOHANSSON C, Thordardottir S, Laffita-Mesa J, Rodriguez-Vieitez E, et al
    Plasma biomarker profiles in autosomal dominant Alzheimer's disease.
    Brain. 2023 Jan 11:awac399. doi: 10.1093.
    PubMed     Abstract available


  65. WHEELOCK MD, Strain JF, Mansfield P, Tu JC, et al
    Brain network decoupling with increased serum neurofilament and reduced cognitive function in Alzheimer's disease.
    Brain. 2023 Jan 10:awac498. doi: 10.1093.
    PubMed     Abstract available


  66. VAN ARENDONK J, Neitzel J, Steketee RME, van Assema DME, et al
    Diabetes and hypertension are related to amyloid-beta burden in the population-based Rotterdam Study.
    Brain. 2023;146:337-348.
    PubMed     Abstract available


  67. KATSUMI Y, Putcha D, Eckbo R, Wong B, et al
    Anterior dorsal attention network tau drives visual attention deficits in posterior cortical atrophy.
    Brain. 2023;146:295-306.
    PubMed     Abstract available


  68. BLOMMER J, Pitcher T, Mustapic M, Eren E, et al
    Extracellular vesicle biomarkers for cognitive impairment in Parkinson's disease.
    Brain. 2023;146:195-208.
    PubMed     Abstract available


    December 2022
  69. GONZALEZ-ORTIZ F, Turton M, Kac PR, Smirnov D, et al
    Brain-derived tau: a novel blood-based biomarker for Alzheimer's disease-type neurodegeneration.
    Brain. 2022 Dec 27:awac407. doi: 10.1093.
    PubMed     Abstract available


  70. KOOP EA, Jacobs HIL
    Untangling white matter fibre changes in Alzheimer's disease and small vessel disease.
    Brain. 2022 Dec 26:awac493. doi: 10.1093.
    PubMed    


  71. WISCH JK, Butt OH, Gordon BA, Schindler SE, et al
    Proteomic clusters underlie heterogeneity in preclinical Alzheimer's disease progression.
    Brain. 2022 Dec 21:awac484. doi: 10.1093.
    PubMed     Abstract available


  72. PERANI D
    The impact of integrated brain molecular PET measures on DLB cognitive phenotype and clinical course.
    Brain. 2022;145:4157-4159.
    PubMed    


    November 2022
  73. MOUSSAVI Z
    Repetitive TMS applied to the precuneus stabilizes cognitive status in Alzheimer's disease.
    Brain. 2022;145:3730-3732.
    PubMed    


  74. OBERSTEIN TJ, Schmidt MA, Florvaag A, Haas AL, et al
    Amyloid-beta levels and cognitive trajectories in non-demented pTau181-positive subjects without amyloidopathy.
    Brain. 2022;145:4032-4041.
    PubMed     Abstract available


  75. BETTHAUSER TJ, Bilgel M, Koscik RL, Jedynak BM, et al
    Multi-method investigation of factors influencing amyloid onset and impairment in three cohorts.
    Brain. 2022;145:4065-4079.
    PubMed     Abstract available


  76. HUGHES TM, Craft S
    Cerebral insulin receptors: a nexus for vascular and metabolic contributions to Alzheimer's disease.
    Brain. 2022 Nov 19:awac433. doi: 10.1093.
    PubMed    


    October 2022
  77. SEYEDSALEHI A, Warrier V, Bethlehem RAI, Perry BI, et al
    Educational attainment, structural brain reserve and Alzheimer's disease: a Mendelian randomization analysis.
    Brain. 2022 Oct 31. pii: 6780317. doi: 10.1093.
    PubMed     Abstract available


  78. NEMY M, Dyrba M, Brosseron F, Buerger K, et al
    Cholinergic white matter pathways along the Alzheimer's disease continuum.
    Brain. 2022 Oct 26. pii: 6775152. doi: 10.1093.
    PubMed     Abstract available


  79. KOCH G, Casula EP, Bonni S, Borghi I, et al
    Precuneus magnetic stimulation for Alzheimer's disease: a randomized, sham-controlled trial.
    Brain. 2022 Oct 25. pii: 6701823. doi: 10.1093.
    PubMed     Abstract available


  80. LECLERC M, Bourassa P, Tremblay C, Caron V, et al
    Cerebrovascular insulin receptors are defective in Alzheimer's disease.
    Brain. 2022 Oct 25. pii: 6761474. doi: 10.1093.
    PubMed     Abstract available


  81. LI X, Ospitalieri S, Robberechts T, Hofmann L, et al
    Seeding, maturation and propagation of amyloid beta-peptide aggregates in Alzheimer's disease.
    Brain. 2022;145:3558-3570.
    PubMed     Abstract available


  82. SINGLETON EH, Fieldhouse JLP, van 't Hooft JJ, Scarioni M, et al
    Social cognition deficits and biometric signatures in the behavioural variant of Alzheimer's disease.
    Brain. 2022 Oct 21. pii: 6765142. doi: 10.1093.
    PubMed     Abstract available


    September 2022
  83. SPOTORNO N, Strandberg O, Vis G, Stomrud E, et al
    Measures of cortical microstructure are linked to amyloid pathology in Alzheimer's disease.
    Brain. 2022 Sep 21. pii: 6710203. doi: 10.1093.
    PubMed     Abstract available


  84. JANELIDZE S, Bali D, Ashton NJ, Barthelemy NR, et al
    Head-to-head comparison of 10 plasma phospho-tau assays in prodromal Alzheimer's disease.
    Brain. 2022 Sep 10. pii: 6695388. doi: 10.1093.
    PubMed     Abstract available


  85. GROOT C, Smith R, Stomrud E, Binette AP, et al
    Phospho-tau with subthreshold tau-PET predicts increased tau accumulation rates in amyloid-positive individuals.
    Brain. 2022 Sep 9. pii: 6695020. doi: 10.1093.
    PubMed     Abstract available


  86. BUCKLEY R
    Sex differences in Alzheimer's disease risk: are immune responses the key?
    Brain. 2022 Sep 2. pii: 6686583. doi: 10.1093.
    PubMed    


    August 2022
  87. RABIN JS, Nichols E, La Joie R, Casaletto KB, et al
    Cerebral amyloid angiopathy interacts with neuritic amyloid plaques to promote tau and cognitive decline.
    Brain. 2022;145:2823-2833.
    PubMed     Abstract available


  88. SNELLMAN A, Lantero-Rodriguez J, Emersic A, Vrillon A, et al
    N-terminal and mid-region tau fragments as fluid biomarkers in neurological diseases.
    Brain. 2022;145:2834-2848.
    PubMed     Abstract available


  89. RIKU Y, Iwasaki Y, Ishigaki S, Akagi A, et al
    Motor neuron TDP-43 proteinopathy in progressive supranuclear palsy and corticobasal degeneration.
    Brain. 2022;145:2769-2784.
    PubMed     Abstract available


  90. SAPKOTA D, Florian C, Doherty BM, White KM, et al
    Aqp4 stop codon readthrough facilitates amyloid-beta clearance from the brain.
    Brain. 2022 Aug 24. pii: 6671408. doi: 10.1093.
    PubMed     Abstract available


  91. INSEL PS, Young CB, Aisen PS, Johnson KA, et al
    Tau positron emission tomography in preclinical Alzheimer's disease.
    Brain. 2022 Aug 13. pii: 6665667. doi: 10.1093.
    PubMed     Abstract available


  92. COURSE MM, Gudsnuk K, Keene CD, Bird TD, et al
    Aberrant splicing of PSEN2, but not PSEN1, in individuals with sporadic Alzheimer's disease.
    Brain. 2022 Aug 11. pii: 6660735. doi: 10.1093.
    PubMed     Abstract available


  93. LUO J, Agboola F, Grant E, Morris JC, et al
    Accelerated longitudinal changes and ordering of Alzheimer disease biomarkers across the adult lifespan.
    Brain. 2022 Aug 4. pii: 6655799. doi: 10.1093.
    PubMed     Abstract available


    July 2022
  94. HUSAIN M
    Molecular pathology and biomarker of progression in Alzheimer's disease.
    Brain. 2022;145:2229-2230.
    PubMed    


  95. GROOT C, Holstege H, Ossenkoppele R
    Do genetic factors contribute to sex-specific differences in resilience to amyloid pathology?
    Brain. 2022;145:2239-2241.
    PubMed    


  96. CASALETTO KB, Nichols E, Aslanyan V, Simone SM, et al
    Sex-specific effects of microglial activation on Alzheimer's disease proteinopathy in older adults.
    Brain. 2022 Jul 23. pii: 6648895. doi: 10.1093.
    PubMed     Abstract available


  97. LONG JM, Coble DW, Xiong C, Schindler SE, et al
    Preclinical Alzheimer's disease biomarkers accurately predict cognitive and neuropathological outcomes.
    Brain. 2022 Jul 22. pii: 6648721. doi: 10.1093.
    PubMed     Abstract available


  98. DEWENTER A, Jacob MA, Cai M, Gesierich B, et al
    Disentangling the effects of Alzheimer's and small vessel disease on white matter fibre tracts.
    Brain. 2022 Jul 21. pii: 6647593. doi: 10.1093.
    PubMed     Abstract available


  99. BIESSELS GJ
    Alzheimer's disease, cerebrovascular disease and dementia: lump, split or integrate?
    Brain. 2022 Jul 15. pii: 6644842. doi: 10.1093.
    PubMed    


  100. WANG Q, Huang X, Su Y, Yin G, et al
    Activation of Wnt/beta-catenin pathway mitigates blood-brain barrier dysfunction in Alzheimer's disease.
    Brain. 2022 Jul 5. pii: 6630034. doi: 10.1093.
    PubMed     Abstract available


    June 2022
  101. GRAHAM NSN
    Progress towards predicting neurodegeneration and dementia after traumatic brain injury.
    Brain. 2022;145:1874-1876.
    PubMed    


  102. JENKINS LM, Wang L, Rosen H, Weintraub S, et al
    A transdiagnostic review of neuroimaging studies of apathy and disinhibition in dementia.
    Brain. 2022;145:1886-1905.
    PubMed     Abstract available


  103. MEHRARAM R, Peraza LR, Murphy NRE, Cromarty RA, et al
    Functional and structural brain network correlates of visual hallucinations in Lewy body dementia.
    Brain. 2022;145:2190-2205.
    PubMed     Abstract available


  104. LEVEY AI, Qiu D, Zhao L, Hu WT, et al
    A phase II study repurposing atomoxetine for neuroprotection in mild cognitive impairment.
    Brain. 2022;145:1924-1938.
    PubMed     Abstract available


  105. TANNER JA, Iaccarino L, Edwards L, Asken BM, et al
    Amyloid, tau and metabolic PET correlates of cognition in early and late-onset Alzheimer's disease.
    Brain. 2022 Jun 28. pii: 6619120. doi: 10.1093.
    PubMed     Abstract available


  106. KAIVOLA K, Shah Z, Chia R, Scholz SW, et al
    Genetic evaluation of dementia with Lewy bodies implicates distinct disease subgroups.
    Brain. 2022;145:1757-1762.
    PubMed     Abstract available


    May 2022
  107. TONIOLO S
    What plasma biomarkers tell us about hippocampal microstructural changes in Alzheimer's disease.
    Brain. 2022 May 25. pii: 6591892. doi: 10.1093.
    PubMed    


  108. DUZEL E, Ziegler G, Berron D, Maass A, et al
    Amyloid pathology but not APOE epsilon4 status is permissive for tau-related hippocampal dysfunction.
    Brain. 2022;145:1473-1485.
    PubMed     Abstract available


  109. KO H, Kim S, Kim K, Jung SH, et al
    Genome-wide association study of occupational attainment as a proxy for cognitive reserve.
    Brain. 2022;145:1436-1448.
    PubMed     Abstract available


  110. MORRIS JC, Weiner M, Xiong C, Beckett L, et al
    Autosomal dominant and sporadic late onset Alzheimer disease share a common in vivo pathophysiology.
    Brain. 2022 May 17. pii: 6587090. doi: 10.1093.
    PubMed     Abstract available


  111. MORRISON MS, Aparicio HJ, Blennow K, Zetterberg H, et al
    Antemortem plasma phosphorylated tau (181) predicts Alzheimer's disease neuropathology and regional tau at autopsy.
    Brain. 2022 May 13. pii: 6585495. doi: 10.1093.
    PubMed     Abstract available



  112. Correction to: Brain amyloid-beta oligomers in ageing and Alzheimer's disease.
    Brain. 2022 May 13. pii: 6585189. doi: 10.1093.
    PubMed    


  113. EISSMAN JM, Dumitrescu L, Mahoney ER, Smith AN, et al
    Sex differences in the genetic architecture of cognitive resilience to Alzheimer's disease.
    Brain. 2022 May 13. pii: 6585174. doi: 10.1093.
    PubMed     Abstract available


  114. ZHU WM, Neuhaus A, Beard DJ, Sutherland BA, et al
    Neurovascular coupling mechanisms in health and neurovascular uncoupling in Alzheimer's disease.
    Brain. 2022 May 13. pii: 6585171. doi: 10.1093.
    PubMed     Abstract available


  115. VROMEN EM, de Boer SCM, Teunissen CE, Rozemuller A, et al
    Biomarker A+T-: is this Alzheimer's disease or not? A combined CSF and pathology study.
    Brain. 2022 May 2. pii: 6576655. doi: 10.1093.
    PubMed     Abstract available


    April 2022
  116. BARKER MS, Gottesman RT, Manoochehri M, Chapman S, et al
    Proposed research criteria for prodromal behavioural variant frontotemporal dementia.
    Brain. 2022;145:1079-1097.
    PubMed     Abstract available


  117. LEGAZ A, Abrevaya S, Dottori M, Gonzalez Campo C, et al
    Multimodal mechanisms of human socially reinforced learning across neurodegenerative diseases.
    Brain. 2022;145:1052-1068.
    PubMed     Abstract available


  118. MESULAM MM, Coventry CA, Bigio EH, Sridhar J, et al
    Neuropathological fingerprints of survival, atrophy and language in primary progressive aphasia.
    Brain. 2022 Apr 20. pii: 6570516. doi: 10.1093.
    PubMed     Abstract available


  119. SHAHID SS, Wen Q, Risacher SL, Farlow MR, et al
    Hippocampal-subfield microstructures and their relation to plasma biomarkers in Alzheimer's disease.
    Brain. 2022 Apr 12. pii: 6566798. doi: 10.1093.
    PubMed     Abstract available


  120. OLIVEROS G, Wallace CH, Chaudry O, Liu Q, et al
    Repurposing ibudilast to mitigate Alzheimer's disease by targeting inflammation.
    Brain. 2022 Apr 12. pii: 6566790. doi: 10.1093.
    PubMed     Abstract available


  121. STEVENSON-HOARE J, Heslegrave A, Leonenko G, Fathalla D, et al
    Plasma biomarkers and genetics in the diagnosis and prediction of Alzheimer's disease.
    Brain. 2022 Apr 6. pii: 6564132. doi: 10.1093.
    PubMed     Abstract available


  122. PADHI S, Sarangi S, Nayak N, Pati A, et al
    OAS1 rs1131454 genetic variant is associated with Alzheimer's disease: an epidemiological analysis.
    Brain. 2022 Apr 6. pii: 6564066. doi: 10.1093.
    PubMed    


    March 2022
  123. JEONG YY, Han S, Jia N, Zhang M, et al
    Broad activation of the Parkin pathway induces synaptic mitochondrial deficits in early tauopathy.
    Brain. 2022;145:305-323.
    PubMed     Abstract available


  124. BENATAR M, Wuu J, McHutchison C, Postuma RB, et al
    Preventing amyotrophic lateral sclerosis: insights from pre-symptomatic neurodegenerative diseases.
    Brain. 2022;145:27-44.
    PubMed     Abstract available


  125. HOSOKAWA M, Masuda-Suzukake M, Shitara H, Shimozawa A, et al
    Development of a novel tau propagation mouse model endogenously expressing 3 and 4 repeat tau isoforms.
    Brain. 2022;145:349-361.
    PubMed     Abstract available


  126. GIACOBINI E, Cuello AC, Fisher A
    Reimagining cholinergic therapy for Alzheimer's disease.
    Brain. 2022 Mar 15. pii: 6548684. doi: 10.1093.
    PubMed     Abstract available


  127. SHETTY AK
    Can rapamycin slow down memory decline in Alzheimer's disease with seizures?
    Brain. 2022 Mar 12. pii: 6547363. doi: 10.1093.
    PubMed    


  128. LAM AD, Shafi MM
    Towards a coherent view of network hyperexcitability in Alzheimer's disease.
    Brain. 2022 Mar 8. pii: 6544859. doi: 10.1093.
    PubMed    


  129. LIN CP, Frigerio I, Boon BDC, Zhou Z, et al
    Structural (dys)connectivity associates with cholinergic cell density in Alzheimer's disease.
    Brain. 2022 Mar 8. pii: 6543231. doi: 10.1093.
    PubMed     Abstract available


  130. GABRIELLI M, Prada I, Joshi P, Falcicchia C, et al
    Microglial large extracellular vesicles propagate early synaptic dysfunction in Alzheimer's disease.
    Brain. 2022 Mar 3. pii: 6541881. doi: 10.1093.
    PubMed     Abstract available


    February 2022
  131. BEAMAN EE, Bonde AN, Ulv Larsen SM, Ozenne B, et al
    Blood-brain barrier permeable beta-blockers linked to lower risk of Alzheimer's disease in hypertension.
    Brain. 2022 Feb 23. pii: 6535129. doi: 10.1093.
    PubMed     Abstract available


  132. PERIS L, Parato J, Qu X, Soleilhac JM, et al
    Tubulin tyrosination regulates synaptic function and is disrupted in Alzheimer's disease.
    Brain. 2022 Feb 11. pii: 6527175. doi: 10.1093.
    PubMed     Abstract available


    January 2022
  133. KARANTH SD, Katsumata Y, Nelson PT, Fardo DW, et al
    Cancer diagnosis is associated with a lower burden of dementia and less Alzheimer's-type neuropathology.
    Brain. 2022 Jan 30. pii: 6517521. doi: 10.1093.
    PubMed     Abstract available


  134. WIESMAN AI, Murman DL, Losh RA, Schantell M, et al
    Spatially resolved neural slowing predicts impairment and amyloid burden in Alzheimer's disease.
    Brain. 2022 Jan 28. pii: 6516524. doi: 10.1093.
    PubMed     Abstract available


  135. MARTINO ADAMI PV, Orellana A, Garcia P, Kleineidam L, et al
    Matrix metalloproteinase 10 is linked to the risk of progression to dementia of the Alzheimer's type.
    Brain. 2022 Jan 28. pii: 6516341. doi: 10.1093.
    PubMed     Abstract available


  136. STERN AM, Liu L, Jin S, Liu W, et al
    A calcium-sensitive antibody isolates soluble amyloid-beta aggregates and fibrils from Alzheimer's disease brain.
    Brain. 2022 Jan 27. pii: 6516009. doi: 10.1093.
    PubMed     Abstract available


  137. ALI M, Falkenhain K, Njiru BN, Murtaza-Ali M, et al
    VEGF signalling causes stalls in brain capillaries and reduces cerebral blood flow in Alzheimer's mice.
    Brain. 2022 Jan 20. pii: 6512043. doi: 10.1093.
    PubMed     Abstract available


  138. BRIDEL C, Somers C, Sieben A, Rozemuller A, et al
    Associating Alzheimer's disease pathology with its cerebrospinal fluid biomarkers.
    Brain. 2022 Jan 13. pii: 6506576. doi: 10.1093.
    PubMed     Abstract available


  139. COOMANS EM, Tomassen J, Ossenkoppele R, Golla SSV, et al
    Genetically identical twins show comparable tau PET load and spatial distribution.
    Brain. 2022 Jan 12. pii: 6504924. doi: 10.1093.
    PubMed     Abstract available


    December 2021
  140. LEE Y, Miller MR, Fernandez MA, Berg EL, et al
    Early lysosome defects precede neurodegeneration with amyloid-beta and tau aggregation in NHE6-null rat brain.
    Brain. 2021 Dec 20. pii: 6470622. doi: 10.1093.
    PubMed     Abstract available


  141. RANASINGHE KG, Kudo K, Hinkley L, Beagle A, et al
    Neuronal synchrony abnormalities associated with subclinical epileptiform activity in early onset Alzheimer's disease.
    Brain. 2021 Dec 17. pii: 6469013. doi: 10.1093.
    PubMed     Abstract available


  142. XHIMA K, Markham-Coultes K, Kofoed RH, Saragovi HU, et al
    Ultrasound delivery of a TrkA agonist confers neuroprotection to Alzheimer-associated pathologies.
    Brain. 2021 Dec 17. pii: 6469023. doi: 10.1093.
    PubMed     Abstract available


  143. TSAI HH, Chen YF, Yen RF, Lo YL, et al
    Plasma soluble TREM2 is associated with white matter lesions independent of amyloid and tau.
    Brain. 2021;144:3371-3380.
    PubMed     Abstract available


  144. PASCOAL TA, Benedet AL, Tudorascu DL, Therriault J, et al
    Longitudinal 18F-MK-6240 tau tangles accumulation follows Braak stages.
    Brain. 2021;144:3517-3528.
    PubMed     Abstract available


  145. ABRAHAMSON EE, Kofler JK, Becker CR, Price JC, et al
    11C-PiB PET can underestimate brain amyloid-beta burden when cotton wool plaques are numerous.
    Brain. 2021 Dec 16. pii: 6464340. doi: 10.1093.
    PubMed     Abstract available


    November 2021
  146. VERDI S, Marquand AF, Schott JM, Cole JH, et al
    Beyond the average patient: how neuroimaging models can address heterogeneity in dementia.
    Brain. 2021;144:2946-2953.
    PubMed     Abstract available


    October 2021
  147. ZHANG Y, Zhang Y, Aman Y, Ng CT, et al
    Amyloid-beta toxicity modulates tau phosphorylation through the PAX6 signalling pathway.
    Brain. 2021;144:2759-2770.
    PubMed     Abstract available


  148. LUCEY BP, Wisch J, Boerwinkle AH, Landsness EC, et al
    Sleep and longitudinal cognitive performance in preclinical and early symptomatic Alzheimer's disease.
    Brain. 2021 Oct 20. pii: 6401973. doi: 10.1093.
    PubMed     Abstract available


  149. LEVY JP, Bezgin G, Savard M, Pascoal TA, et al
    18F-MK-6240 tau-PET in genetic frontotemporal dementia.
    Brain. 2021 Oct 19. pii: 6402002. doi: 10.1093.
    PubMed     Abstract available


  150. MAGUSALI N, Graham AC, Piers TM, Panichnantakul P, et al
    A genetic link between risk for Alzheimer's disease and severe COVID-19 outcomes via the OAS1 gene.
    Brain. 2021 Oct 7. pii: 6382473. doi: 10.1093.
    PubMed     Abstract available


  151. KHAN AF, Adewale Q, Baumeister TR, Carbonell F, et al
    Personalized brain models identify neurotransmitter receptor changes in Alzheimer's disease.
    Brain. 2021 Oct 4. pii: 6380944. doi: 10.1093.
    PubMed     Abstract available


  152. SCHUMACHER J, Ray NJ, Hamilton CA, Donaghy PC, et al
    Cholinergic white matter pathways in dementia with Lewy bodies and Alzheimer's disease.
    Brain. 2021 Oct 4. pii: 6380941. doi: 10.1093.
    PubMed     Abstract available


    September 2021

  153. Erratum to: Cardiovascular brain impulses in Alzheimer's disease.
    Brain. 2021 Sep 22. pii: 6373794. doi: 10.1093.
    PubMed    


  154. STOTHART G, Smith LJ, Milton A, Coulthard E, et al
    A passive and objective measure of recognition memory in Alzheimer's disease using Fastball memory assessment.
    Brain. 2021 Sep 20. pii: 6372384. doi: 10.1093.
    PubMed     Abstract available


    August 2021
  155. KHAN AR, Ottoy J, Goubran M
    Towards a comprehensive 3D mapping of tau progression in early Alzheimer's disease.
    Brain. 2021 Aug 23. pii: 6356553. doi: 10.1093.
    PubMed    


  156. DAVILA-BOUZIGUET E, Casoliba-Melich A, Targa-Fabra G, Galera-Lopez L, et al
    Functional protection in J20/VLW mice: a model of non-demented with Alzheimer's disease neuropathology.
    Brain. 2021 Aug 23. pii: 6356505. doi: 10.1093.
    PubMed     Abstract available


  157. BOYLE PA, Wang T, Yu L, Wilson RS, et al
    To what degree is late life cognitive decline driven by age-related neuropathologies?
    Brain. 2021;144:2166-2175.
    PubMed     Abstract available


  158. HOLLAND N, Malpetti M, Rittman T, Mak EE, et al
    Molecular pathology and synaptic loss in primary tauopathies: an 18F-AV-1451 and 11C-UCB-J PET study.
    Brain. 2021 Aug 16. pii: 6353021. doi: 10.1093.
    PubMed     Abstract available


  159. STROM A, Iaccarino L, Edwards L, Lesman-Segev OH, et al
    Cortical hypometabolism reflects local atrophy and tau pathology in symptomatic Alzheimer's disease.
    Brain. 2021 Aug 9. pii: 6346980. doi: 10.1093.
    PubMed     Abstract available


    July 2021
  160. PAUMIER A, Boisseau S, Jacquier-Sarlin M, Pernet-Gallay K, et al
    Astrocyte-neuron interplay is critical for Alzheimer's disease pathogenesis and is rescued by TRPA1 channel blockade.
    Brain. 2021 Jul 24. pii: 6327685. doi: 10.1093.
    PubMed     Abstract available


  161. GOURMAUD S, Stewart DA, Irwin DJ, Roberts N, et al
    The role of mTORC1 activation in seizure-induced exacerbation of Alzheimer's disease.
    Brain. 2021 Jul 15. pii: 6321945. doi: 10.1093.
    PubMed     Abstract available


  162. BERRON D, van Westen D, Ossenkoppele R, Strandberg O, et al
    Corrigendum to: Medial temporal lobe connectivity and its associations with cognition in early Alzheimer's disease.
    Brain. 2021 Jul 14. pii: 6321152. doi: 10.1093.
    PubMed    


  163. PEREIRA JB, Janelidze S, Smith R, Mattsson-Carlgren N, et al
    Plasma GFAP is an early marker of amyloid-beta but not tau pathology in Alzheimer's disease.
    Brain. 2021 Jul 14. pii: 6321226. doi: 10.1093.
    PubMed     Abstract available


  164. BAILES SM, Lewis LD
    Distinct cardiac-locked brain pulsations in Alzheimer's disease.
    Brain. 2021 Jul 9. pii: 6318392. doi: 10.1093.
    PubMed    


  165. HORIE K, Barthelemy NR, Sato C, Bateman RJ, et al
    Corrigendum to: CSF tau microtubule binding region identifies tau tangle and clinical stages of Alzheimer's disease.
    Brain. 2021 Jul 3. pii: 6313379. doi: 10.1093.
    PubMed    


    June 2021
  166. RIES M, Watts H, Mota BC, Lopez MY, et al
    Annexin A1 restores cerebrovascular integrity concomitant with reduced amyloid-beta and tau pathology.
    Brain. 2021;144:1526-1541.
    PubMed     Abstract available


  167. MATTHEWS DC, Mao X, Dowd K, Tsakanikas D, et al
    Riluzole, a glutamate modulator, slows cerebral glucose metabolism decline in patients with Alzheimer's disease.
    Brain. 2021 Jun 18. pii: 6305835. doi: 10.1093.
    PubMed     Abstract available


  168. PATEL AG, Nehete PN, Krivoshik SR, Pei X, et al
    Innate immunity stimulation via CpG oligodeoxynucleotides ameliorates Alzheimer's disease pathology in aged squirrel monkeys.
    Brain. 2021 Jun 15. pii: 6297373. doi: 10.1093.
    PubMed     Abstract available


  169. SCHUMACHER J, Gunter JL, Przybelski SA, Jones DT, et al
    Dementia with Lewy bodies: association of Alzheimer pathology with functional connectivity networks.
    Brain. 2021 Jun 11. pii: 6296589. doi: 10.1093.
    PubMed     Abstract available


    May 2021

  170. Erratum to: The development and convergence of co-pathologies in Alzheimer's disease.
    Brain. 2021 May 23. pii: 6282423. doi: 10.1093.
    PubMed    


  171. DEHGHANI N, Bras J, Guerreiro R
    Erratum to: How understudied populations have contributed to our understanding of Alzheimer's disease genetics.
    Brain. 2021 May 20. pii: 6279241. doi: 10.1093.
    PubMed    


    April 2021
  172. O'CONNOR A, Pannee J, Poole T, Arber C, et al
    Plasma amyloid-beta ratios in autosomal dominant Alzheimer's disease: the influence of genotype.
    Brain. 2021 Apr 23. pii: 6248083. doi: 10.1093.
    PubMed     Abstract available


  173. DEHGHANI N, Bras J, Guerreiro R
    How understudied populations have contributed to our understanding of Alzheimer's disease genetics.
    Brain. 2021 Apr 23. pii: 6247156. doi: 10.1093.
    PubMed     Abstract available


  174. YAO Y, Kang SS, Xia Y, Wang ZH, et al
    A delta-secretase-truncated APP fragment activates CEBPB, mediating Alzheimer's disease pathologies.
    Brain. 2021 Apr 20. pii: 6242262. doi: 10.1093.
    PubMed     Abstract available



  175. Erratum to: Time course of phosphorylated-tau181 in blood across the Alzheimer's disease spectrum.
    Brain. 2021 Apr 20. pii: 6238673. doi: 10.1093.
    PubMed    


  176. OZAWA S, Hori Y, Shimizu Y, Taniguchi A, et al
    Photo-oxygenation by a biocompatible catalyst reduces amyloid-beta levels in Alzheimer's disease mice.
    Brain. 2021 Apr 14. pii: 6224831. doi: 10.1093.
    PubMed     Abstract available


  177. TOME SO, Thal DR
    Co-pathologies in Alzheimer's disease: just multiple pathologies or partners in crime?
    Brain. 2021;144:706-708.
    PubMed    



  178. Corrigendum to: Monitoring the progression of Alzheimer's disease with tau-PET.
    Brain. 2021 Apr 6. pii: 6213355. doi: 10.1093.
    PubMed    


    March 2021
  179. RAJNA Z, Mattila H, Huotari N, Tuovinen T, et al
    Cardiovascular brain impulses in Alzheimer's disease.
    Brain. 2021 Mar 31. pii: 6206368. doi: 10.1093.
    PubMed     Abstract available


  180. YAP SY, Frias B, Wren MC, Scholl M, et al
    Discriminatory ability of next-generation tau PET tracers for Alzheimer's disease.
    Brain. 2021 Mar 20. pii: 6179104. doi: 10.1093.
    PubMed     Abstract available


  181. EWERS M, Luan Y, Frontzkowski L, Neitzel J, et al
    Segregation of functional networks is associated with cognitive resilience in Alzheimer's disease.
    Brain. 2021 Mar 16. pii: 6174116. doi: 10.1093.
    PubMed     Abstract available


  182. ASBY D, Boche D, Allan S, Love S, et al
    Systemic infection exacerbates cerebrovascular dysfunction in Alzheimer's disease.
    Brain. 2021 Mar 16. pii: 6173392. doi: 10.1093.
    PubMed     Abstract available


  183. SPINA S, La Joie R, Petersen C, Nolan AL, et al
    Comorbid neuropathological diagnoses in early versus late-onset Alzheimer's disease.
    Brain. 2021 Mar 9. pii: 6164966. doi: 10.1093.
    PubMed     Abstract available


  184. HUSAIN M
    Blood tests to screen for Alzheimer's disease.
    Brain. 2021;144:355-356.
    PubMed    


  185. KIM JH, Afridi R, Han J, Jung HG, et al
    Gamma subunit of complement component 8 is a neuroinflammation inhibitor.
    Brain. 2021;144:528-552.
    PubMed     Abstract available


    February 2021
  186. JAGUST W
    Integrating events in the disintegration of Alzheimer's disease.
    Brain. 2021;144:11-14.
    PubMed    


  187. TIJMS BM, Teunissen CE
    Concatenating plasma p-tau to Alzheimer's disease.
    Brain. 2021;144:14-17.
    PubMed    


    January 2021
  188. KESHAVAN A, Pannee J, Karikari TK, Rodriguez JL, et al
    Population-based blood screening for preclinical Alzheimer's disease in a British birth cohort at age 70.
    Brain. 2021 Jan 22. pii: 6105867. doi: 10.1093.
    PubMed     Abstract available



  189. Erratum to: Alzheimer's disease brain-derived extracellular vesicles spread tau pathology in interneurons.
    Brain. 2021 Jan 12. pii: 6091150. doi: 10.1093.
    PubMed    


    December 2020
  190. JOHNSON JCS, Marshall CR, Weil RS, Bamiou DE, et al
    Hearing and dementia: from ears to brain.
    Brain. 2020 Dec 22. pii: 6044086. doi: 10.1093.
    PubMed     Abstract available


  191. MONTERO-CRESPO M, Dominguez-Alvaro M, Alonso-Nanclares L, DeFelipe J, et al
    Three-dimensional analysis of synaptic organization in the hippocampal CA1 field in Alzheimer's disease.
    Brain. 2020 Dec 16. pii: 6038920. doi: 10.1093.
    PubMed     Abstract available


  192. HORIE K, Barthelemy NR, Sato C, Bateman RJ, et al
    CSF tau microtubule binding region identifies tau tangle and clinical stages of Alzheimer's disease.
    Brain. 2020 Dec 7. pii: 6024973. doi: 10.1093.
    PubMed     Abstract available


  193. TEUNISSEN CE, Thijssen EH, Verberk IMW
    Plasma p-tau217: from 'new kid' to most promising candidate for Alzheimer's disease blood test.
    Brain. 2020;143:3170-3172.
    PubMed    


  194. PEREIRA JB, Janelidze S, Ossenkoppele R, Kvartsberg H, et al
    Untangling the association of amyloid-beta and tau with synaptic and axonal loss in Alzheimer's disease.
    Brain. 2020 Dec 5. pii: 6024803. doi: 10.1093.
    PubMed     Abstract available


  195. TIJMS BM, Gobom J, Reus L, Jansen I, et al
    Pathophysiological subtypes of Alzheimer's disease based on cerebrospinal fluid proteomics.
    Brain. 2020;143:3776-3792.
    PubMed     Abstract available


  196. SMITH R, Strandberg O, Mattsson-Carlgren N, Leuzy A, et al
    The accumulation rate of tau aggregates is higher in females and younger amyloid-positive subjects.
    Brain. 2020;143:3805-3815.
    PubMed     Abstract available


  197. FLORES-AGUILAR L, Iulita MF, Kovecses O, Torres MD, et al
    Evolution of neuroinflammation across the lifespan of individuals with Down syndrome.
    Brain. 2020;143:3653-3671.
    PubMed     Abstract available


    November 2020
  198. MOSCOSO A, Grothe MJ, Ashton NJ, Karikari TK, et al
    Time course of phosphorylated-tau181 in blood across the Alzheimer's disease spectrum.
    Brain. 2020 Nov 30. pii: 6012955. doi: 10.1093.
    PubMed     Abstract available


  199. BRIER MR, Day GS
    Serum neurofilament light chain uncovers neurodegeneration early in the course of Alzheimer's disease.
    Brain. 2020 Nov 30. pii: 6012788. doi: 10.1093.
    PubMed    


  200. SUR C, Kost J, Scott D, Adamczuk K, et al
    BACE inhibition causes rapid, regional, and non-progressive volume reduction in Alzheimer's disease brain.
    Brain. 2020 Nov 30. pii: 6012787. doi: 10.1093.
    PubMed     Abstract available


  201. RUAN Z, Pathak D, Venkatesan Kalavai S, Yoshii-Kitahara A, et al
    Alzheimer's disease brain-derived extracellular vesicles spread tau pathology in interneurons.
    Brain. 2020 Nov 27. pii: 6007752. doi: 10.1093.
    PubMed     Abstract available


  202. BENEDET AL, Leuzy A, Pascoal TA, Ashton NJ, et al
    Stage-specific links between plasma neurofilament light and imaging biomarkers of Alzheimer's disease.
    Brain. 2020 Nov 19. pii: 5990278. doi: 10.1093.
    PubMed     Abstract available


  203. JIA L, Li F, Wei C, Zhu M, et al
    Prediction of Alzheimer's disease using multi-variants from a Chinese genome-wide association study.
    Brain. 2020 Nov 14. pii: 5981992. doi: 10.1093.
    PubMed     Abstract available


  204. LIU KY, Reeves S, McAleese KE, Attems J, et al
    Neuropsychiatric symptoms in limbic-predominant age-related TDP-43 encephalopathy and Alzheimer's disease.
    Brain. 2020 Nov 14. pii: 5981742. doi: 10.1093.
    PubMed     Abstract available


  205. JI X, Liu G
    rs34331204 regulates TSPAN13 expression and contributes to Alzheimer's disease with sex differences.
    Brain. 2020 Nov 11. pii: 5974904. doi: 10.1093.
    PubMed    


  206. DUMITRESCU L, Hohman TJ
    Reply: rs34331204 regulates TSPAN13 expression and contributes to Alzheimer's disease with sex differences.
    Brain. 2020 Nov 11. pii: 5974883. doi: 10.1093.
    PubMed    


  207. JOSEPHS KA, Martin PR, Weigand SD, Tosakulwong N, et al
    Protein contributions to brain atrophy acceleration in Alzheimer's disease and primary age-related tauopathy.
    Brain. 2020 Nov 5. pii: 5956321. doi: 10.1093.
    PubMed     Abstract available


  208. SOLEIMANI-MEIGOONI DN, Iaccarino L, La Joie R, Baker S, et al
    18F-flortaucipir PET to autopsy comparisons in Alzheimer's disease and other neurodegenerative diseases.
    Brain. 2020 Nov 3. pii: 5952719. doi: 10.1093.
    PubMed     Abstract available


    October 2020
  209. MATTSSON-CARLGREN N, Janelidze S, Palmqvist S, Cullen N, et al
    Longitudinal plasma p-tau217 is increased in early stages of Alzheimer's disease.
    Brain. 2020 Oct 17. pii: 5929275. doi: 10.1093.
    PubMed     Abstract available


    September 2020
  210. HARDY CJD, Yong KXX, Goll JC, Crutch SJ, et al
    Impairments of auditory scene analysis in posterior cortical atrophy.
    Brain. 2020 Sep 1. pii: 5900355. doi: 10.1093.
    PubMed     Abstract available


    July 2020
  211. PASCOAL TA, Therriault J, Benedet AL, Savard M, et al
    18F-MK-6240 PET for early and late detection of neurofibrillary tangles.
    Brain. 2020 Jul 16. pii: 5872095. doi: 10.1093.
    PubMed     Abstract available


    June 2020
  212. PRZYBYLA M, van Eersel J, van Hummel A, van der Hoven J, et al
    Onset of hippocampal network aberration and memory deficits in P301S tau mice are associated with an early gene signature.
    Brain. 2020;143:1889-1904.
    PubMed     Abstract available


    January 2020
  213. ROBINSON JL, Richardson H, Xie SX, Suh E, et al
    The development and convergence of co-pathologies in Alzheimer's disease.
    Brain. 2020 Jan 15. pii: 6101614. doi: 10.1093.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.